Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Zeitschrift Fur Gastroenterologie|September 7, 2002
TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?V Gülberg, A L GerbesEuropean Journal of Clinical Investigation|December 1, 1995
Relation of endothelins to volume regulating neurohumoral systems in patients with cirrhosis of the liverV Gülberg, A L GerbesZeitschrift Fur Gastroenterologie|January 15, 2005
[Advances in therapy for ascites and hepatorenal syndrome]A L Gerbes, V GülbergEuropean Journal of Clinical Investigation|August 22, 2006
Endothelin and endothelin receptor antagonism in portopulmonary hypertensionW Neuhofer, V Gülberg, A L GerbesHepatology (Baltimore, Md.)|September 25, 1999
Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamineV Gülberg, M Bilzer, A L GerbesGut|January 5, 2002
Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liverA L Gerbes, V Gülberg, M Bilzer, et al.Journal of Hepatology|August 1, 1995
Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamicsS Møller, V Gülberg, J H Henriksen, et al.Gut|November 15, 2000
Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failureV Gülberg, S Møller, J H Henriksen, et al.Life Sciences|January 1, 1992
Endothelin-3 like immunoreactivity in plasma of patients with cirrhosis of the liverV Gülberg, A L Gerbes, A M Vollmar, et al.Pageof 11